Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04851678 · ClinicalTrials.gov registry record

Longitudinal Impact of Stressors in Adults With Tourette Syndrome

A clinical trial of Tourette Syndrome, sponsored by Vanderbilt University Medical Center.

Recruiting
Registry status
140
Enrollment target
1
Study location

NCT04851678 is a study of Tourette Syndrome that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 140 participants, above the 82-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (71% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04851678, a study of Tourette Syndrome, is actively recruiting participants, sponsored by Vanderbilt University Medical Center.

RECRUITING
Registry status
140 participants
Enrollment target
1
Study location

Study Summary

The Investigators propose a two-year, longitudinal pilot study of TS adults (\>18) to determine impact of lifetime environmental stress exposure on tic severity, psychiatric comorbidity severity, and health-related quality of life (HRQOL).

Conditions Studied

Interventions

  • OTHER None - observational study

Study Locations (1)

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 140 participants
Start Date 2021-09-30
Est. Completion 2027-06-30

What the Registry Record Tells You About NCT04851678

The ClinicalTrials.gov registry entry for NCT04851678 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 82-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (71% higher). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tourette Syndrome appearing as the primary indexed condition, and to 1 intervention - of which None - observational study is the first listed.

NCT04851678 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT04851678 about?

NCT04851678 is a clinical study titled "Longitudinal Impact of Stressors in Adults With Tourette Syndrome". The Investigators propose a two-year, longitudinal pilot study of TS adults (\>18) to determine impact of lifetime environmental stress exposure on tic severity, psychiatric comorbidity severity, and health-related quality of life (HRQOL).

What is the current status of trial NCT04851678?

This trial is currently recruiting. The enrollment target is 140 participants. The study started on 2021-09-30. Estimated completion is 2027-06-30.

What conditions does trial NCT04851678 study?

This clinical trial studies the following conditions: Tourette Syndrome.

What interventions are being tested in trial NCT04851678?

The interventions under investigation include: None - observational study (OTHER).

Who is sponsoring clinical trial NCT04851678?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04851678 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tourette Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.